目标导向围术期白蛋白替代与标准治疗减少术后并发症的随机临床试验(SuperAdd试验)
这项单中心随机对照试验纳入美国麻醉医师协会体质状态3至4级或接受高风险手术的成人患者,血清白蛋白低于30 g/L者随机接受目标导向白蛋白替代维持血清浓度大于30 g/L或标准治疗。干预组300例中254例(84.7%)发生至少1个Clavien-Dindo分级≥2的术后并发症,标准治疗组300例中262例(87.3%)发生,风险差-2.7%(95%CI -8.3%至2.9%)。作者结论为围术期维持血清白蛋白大于30 g/L不能在高风险非心脏手术患者中普遍推荐。
要点
- 干预组84.7%发生Clavien-Dindo≥2并发症,标准治疗组87.3%,风险差-2.7%(95%CI -8.3%至2.9%)。
- 2509例纳入患者中600例(23.9%)出现血清白蛋白低于30 g/L。
- 作者认为围术期维持血清白蛋白大于30 g/L不能在高风险非心脏手术患者中普遍推荐。
核心结论
- 围术期维持血清白蛋白浓度大于30 g/L不能在高风险非心脏手术患者中普遍推荐。
研究设计与样本
- 单中心、随机、对照、结局评估者盲法临床试验,纳入美国麻醉医师协会体质状态分级3至4级或接受高风险手术的成人患者。
- 血清白蛋白浓度降至低于30 g/L的患者随机分配至目标导向白蛋白替代组(维持血清浓度大于30 g/L)或标准治疗组,直至从麻醉后中间监护病房出院。
- 标准治疗仅允许对血清浓度低于20 g/L且血流动力学不稳定的患者进行白蛋白替代。
主要发现
- 2509例纳入患者中600例(23.9%)出现血清白蛋白浓度低于30 g/L。
- 干预组299例(99.7%)接受了人白蛋白60 g(40-80 g)替代,标准治疗组54例(18.0%)接受了白蛋白替代。
- 干预组300例中254例(84.7%)发生至少1个Clavien-Dindo分级≥2的术后并发症,标准治疗组300例中262例(87.3%)发生,风险差-2.7%(95%CI -8.3%至2.9%)。
关键数值与推荐
- 主要结局为术后第15天前在9个领域(肺部、感染、心血管、神经、肾脏、胃肠、伤口、疼痛和血液学)中至少1个领域发生Clavien-Dindo分级≥2的术后并发症。
- 目标导向白蛋白替代的血清白蛋白目标阈值为大于30 g/L。
- 标准治疗中白蛋白替代仅允许用于血清浓度低于20 g/L且血流动力学不稳定的患者。
临床怎么用
- 原文结论未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate whether goal-directed albumin substitution during surgery and postanesthesia care to maintain a serum albumin concentration >30 g/L can reduce postoperative complications. BACKGROUND: Hypoalbuminemia is associated with numerous postoperative complications. Since albumin has important physiological functions, substitution of patients with hypoalbuminemia is worth considering. METHODS: We conducted a single-center, randomized, controlled, outcome assessor-blinded clinical trial in adult patients, American Society of Anesthesiologists physical status classification 3 to 4 or undergoing high-risk surgery. Patients, whose serum albumin concentration dropped <30 g/L were randomly assigned to goal-directed albumin substitution maintaining serum concentration >30 g/L or to standard care until discharge from the postanesthesia intermediate care unit. Standard of care allowed albumin substitution in hemodynamic instable patients with serum concentration <20 g/L, only. Primary outcome was the incidence of postoperative complications ≥2 according to the Clavien-Dindo Classification in at least 1 of 9 domains (pulmonary, infectious, cardiovascular, neurological, renal, gastrointestinal, wound, pain, and hematological) until postoperative day 15. RESULTS: Of 2509 included patients, 600 (23.9%) developed serum albumin concentrations <30 g/L. Human albumin 60 g (40-80 g) was substituted to 299 (99.7%) patients in the intervention group and to 54 (18.0%) in the standard care group. At least 1 postoperative complication classified as Clavien-Dindo Classification ≥2 occurred in 254 of 300 patients (84.7%) in the intervention group and in 262 of 300 (87.3%) in the standard treatment group (risk difference -2.7%, 95% CI, -8.3% to 2.9%). CONCLUSION: Maintaining serum albumin concentration of >30 g/L perioperatively cannot generally be recommended in high-risk noncardiac surgery patients.
引用
- Schaller SJ, Fuest K, Ulm B, et al. Goal-directed Perioperative Albumin Substitution Versus Standard of Care to Reduce Postoperative Complications: A Randomized Clinical Trial (SuperAdd Trial). Ann Surg. 2023. PMID: 37477023. doi:10.1097/SLA.0000000000006030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。